OPKO Health Operating Expenses 2010-2024 | OPK

OPKO Health operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
OPKO Health Annual Operating Expenses
(Millions of US $)
2023 $1,021
2022 $1,230
2021 $1,756
2020 $1,378
2019 $1,176
2018 $1,161
2017 $1,242
2016 $1,214
2015 $590
2014 $237
2013 $176
2012 $84
2011 $51
2010 $40
2009 $27
OPKO Health Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $159
2024-06-30 $244
2024-03-31 $245
2023-12-31 $251
2023-09-30 $243
2023-06-30 $258
2023-03-31 $268
2022-12-31 $241
2022-09-30 $268
2022-06-30 $321
2022-03-31 $402
2021-12-31 $464
2021-09-30 $348
2021-06-30 $437
2021-03-31 $507
2020-12-31 $445
2020-09-30 $406
2020-06-30 $274
2020-03-31 $252
2019-12-31 $337
2019-09-30 $268
2019-06-30 $274
2019-03-31 $298
2018-12-31 $312
2018-09-30 $283
2018-06-30 $269
2018-03-31 $298
2017-12-31 $319
2017-09-30 $294
2017-06-30 $318
2017-03-31 $312
2016-12-31 $245
2016-09-30 $322
2016-06-30 $329
2016-03-31 $319
2015-12-31 $284
2015-09-30 $151
2015-06-30 $68
2015-03-31 $87
2014-12-31 $58
2014-09-30 $68
2014-06-30 $58
2014-03-31 $53
2013-12-31 $57
2013-09-30 $40
2013-06-30 $42
2013-03-31 $38
2012-12-31 $26
2012-09-30 $21
2012-06-30 $20
2012-03-31 $18
2011-12-31 $14
2011-09-30 $13
2011-06-30 $13
2011-03-31 $11
2010-12-31 $5
2010-09-30 $10
2010-06-30 $13
2010-03-31 $12
2009-12-31 $1
2009-09-30 $7
2009-06-30 $8
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.106B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $194.739B 23.76
Intuitive Surgical (ISRG) United States $191.917B 100.34
Alcon (ALC) Switzerland $42.138B 28.19
Edwards Lifesciences (EW) United States $41.404B 26.29
IQVIA Holdings (IQV) United States $34.726B 19.13
IDEXX Laboratories (IDXX) United States $34.092B 40.15
DexCom (DXCM) United States $29.248B 44.05
STERIS (STE) Ireland $20.926B 24.09
Waters (WAT) United States $20.468B 30.26
SONOVA HOLDING (SONVY) Switzerland $20.297B 0.00
Hologic (HOLX) United States $18.250B 19.26
Fresenius Medical Care AG KGaA (FMS) Germany $12.969B 13.31
Sysmex ADR (SSMXY) Japan $12.688B 39.79
Globus Medical (GMED) United States $11.345B 28.73
Penumbra (PEN) United States $9.100B 89.14
Teleflex (TFX) United States $8.967B 14.30
Masimo (MASI) United States $8.754B 42.36
Glaukos (GKOS) United States $7.951B 0.00
PROCEPT BioRobotics (PRCT) United States $4.883B 0.00
Integer Holdings (ITGR) United States $4.479B 25.38
Veracyte (VCYT) United States $3.034B 91.05
Inari Medical (NARI) United States $2.984B 0.00
LivaNova (LIVN) United Kingdom $2.789B 16.10
TransMedics (TMDX) United States $2.783B 88.21
Nihon Kohden (NHNKY) Japan $2.293B 17.42
Elekta AB (EKTAY) Sweden $2.192B 17.86
Tandem Diabetes Care (TNDM) United States $1.830B 0.00
RxSight (RXST) United States $1.819B 0.00
Integra LifeSciences Holdings (IART) United States $1.766B 9.23
Alphatec Holdings (ATEC) United States $1.357B 0.00
Artivion (AORT) United States $1.129B 74.81
Pulse Biosciences (PLSE) United States $1.048B 0.00
Paragon 28 (FNA) United States $0.879B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.818B 13.91
ORTHOFIX MEDICAL INC (OFIX) United States $0.716B 0.00
IRadimed (IRMD) United States $0.650B 35.10
OrthoPediatrics (KIDS) United States $0.589B 0.00
AxoGen (AXGN) United States $0.561B 0.00
Mesa Laboratories (MLAB) United States $0.542B 12.77
SiBone (SIBN) United States $0.517B 0.00
Treace Medical Concepts (TMCI) United States $0.483B 0.00
Pacific Biosciences Of California (PACB) United States $0.471B 0.00
Tactile Systems Technology (TCMD) United States $0.378B 20.48
Semler Scientific (SMLR) United States $0.337B 22.60
CVRx (CVRX) United States $0.326B 0.00
Delcath Systems (DCTH) United States $0.317B 0.00
ClearPoint Neuro (CLPT) United States $0.303B 0.00
NeuroPace (NPCE) United States $0.274B 0.00
AngioDynamics (ANGO) United States $0.273B 0.00
Inogen (INGN) United States $0.226B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.185B 0.00
Atossa Genetics (ATOS) United States $0.161B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Nevro (NVRO) United States $0.159B 0.00
KORU Medical Systems (KRMD) United States $0.152B 0.00
Sensus Healthcare (SRTS) United States $0.137B 14.68
Spectral Diagnostics (EDTXF) Canada $0.112B 0.00
EDAP TMS S.A (EDAP) France $0.089B 0.00
WORK Medical Technology Group (WOK) China $0.088B 0.00
LENSAR (LNSR) United States $0.087B 0.00
908 Devices (MASS) United States $0.086B 0.00
Covalon Technologies (CVALF) Canada $0.078B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.055B 0.00
Rapid Micro Biosystems (RPID) United States $0.047B 0.00
Accelerate Diagnostics (AXDX) United States $0.044B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Neuronetics (STIM) United States $0.023B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Aspira Women's Health (AWH) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.010B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00